Among the large number of new molecules reported as anticancer agents, gold(III)-dithiocarbamato complexes were found to be potentially better than other chemotherapeutics. Our compounds, has been designed to combine the \u2018bullet\u2019 character of the metal center with the stabilizing effect of the sulfur chelating ligands. Moreover, the targeting properties of the peptide moiety recognized by PEPTs peptide transporters, grant a marked cell penetrating properties which results in good antitumor activity together with negligible toxicity. Two compounds in particular, dubbed AuD8 and AuD6, have been selected as potential candidates for the development
Gold(III)-dithiocarbamato complexes have recently gained increasing attention as potential anticance...
The accidental discovery of the anticancer properties of cisplatin in the mid 1960s has triggered th...
The unquestionable therapeutic success of the anticancer drug cisplatin and its second and third gen...
Among the large number of new molecules reported as innovative anticancer agents characterized by ...
Gold(III)-dithiocarbamato complexes have recently gained increasing attention as potential anticance...
As a further extension of our research work focusing on the development of gold(III)- dithiocarbamat...
The accidental discovery of the anticancer properties of cisplatin in the mid-1960s triggered the de...
Background: Recently, novel gold(III)-dithiocarbamato peptidomimetics, designed to target peptide tr...
At present, though there is no clinically available antineoplastic drug that acts selectively on the...
Five new Au-III-peptidodithiocarbamato complexes of the type [(AuBr2)-Br-III(dtc-AA(1)-AA(2)-OR] (in...
The invention concerns Au(III) complexes with oligopeptides which are able to both maintain the anti...
Since the serendipitous discovery of cisplatin, platinum-based drugs have become well-established an...
The invention concerns Au(III) complexes of the type [(AuX2)-X-III(Pdtc)] (X=halogen, pseudo-halogen...
Platinum-based drugs are well-established as effective antitumor agents, the progenitor being cispla...
In this review paper we aim at giving a detailed overview on our research work devoted to the design...
Gold(III)-dithiocarbamato complexes have recently gained increasing attention as potential anticance...
The accidental discovery of the anticancer properties of cisplatin in the mid 1960s has triggered th...
The unquestionable therapeutic success of the anticancer drug cisplatin and its second and third gen...
Among the large number of new molecules reported as innovative anticancer agents characterized by ...
Gold(III)-dithiocarbamato complexes have recently gained increasing attention as potential anticance...
As a further extension of our research work focusing on the development of gold(III)- dithiocarbamat...
The accidental discovery of the anticancer properties of cisplatin in the mid-1960s triggered the de...
Background: Recently, novel gold(III)-dithiocarbamato peptidomimetics, designed to target peptide tr...
At present, though there is no clinically available antineoplastic drug that acts selectively on the...
Five new Au-III-peptidodithiocarbamato complexes of the type [(AuBr2)-Br-III(dtc-AA(1)-AA(2)-OR] (in...
The invention concerns Au(III) complexes with oligopeptides which are able to both maintain the anti...
Since the serendipitous discovery of cisplatin, platinum-based drugs have become well-established an...
The invention concerns Au(III) complexes of the type [(AuX2)-X-III(Pdtc)] (X=halogen, pseudo-halogen...
Platinum-based drugs are well-established as effective antitumor agents, the progenitor being cispla...
In this review paper we aim at giving a detailed overview on our research work devoted to the design...
Gold(III)-dithiocarbamato complexes have recently gained increasing attention as potential anticance...
The accidental discovery of the anticancer properties of cisplatin in the mid 1960s has triggered th...
The unquestionable therapeutic success of the anticancer drug cisplatin and its second and third gen...